Skip to NavigationSkip to content

News

Why some patients respond to immunotherapy and others don't is a mystery; however, another piece of the jigsaw may been revealed in recent research,...
It has been announced that I trial will begin in London offering the public GP consultations through their smartphone. The service will be provided...
Just last week Novartis revealed it had applied to the FDA for a new indication in diffuse large B-cell lymphoma (DLBCL) for its CAR-T treatment,...
MSD withdraws Keytruda in Europe for lung cancer, Pfizer begins auction of its consumer health division, and Novartis moves to bolster its oncology...
There has been a raft of changes at senior levels of GSK since Emma Walmsley took over the role from Andrew Witty, with the latest seeing its R&D...
The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK CEO tasked to lead a...
GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a...
A tough second day in the office for new CEO, Schultz, saw the release of Teva's Q3 financials and 16% shaved off the share price of the company.
The FDA has issued a warning over cannabis-based therapies which promise the ability to cure cancer, asserting that such treatments which provide...
Sanofi readjusted its 2017 financial expectations after its third-quarter results came in lower than projected. The company revealed that net...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches